Gelteq Limited Ordinary Shares (GELS) Stock Analysis

Gelteq Limited Ordinary Shares (GELS) is a publicly traded company in the HEALTHCARE sector. It trades at $0.48, carries a market capitalization of $5.19M. This page summarizes the public market data, fundamentals, and frequently asked questions for GELS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

Gelteq Limited Ordinary Shares currently has a Neutral sentiment score of 0.09.

About Gelteq Limited Ordinary Shares

Gelteq Limited (GELS) is a pioneering biotechnology company based in Caulfield, Australia, dedicated to the development and commercialization of innovative gel-based drug delivery systems for both human and veterinary medicine. Employing advanced technologies, Gelteq is focused on enhancing the effectiveness and safety of therapeutic treatments, thereby establishing itself as a significant entity within the biopharmaceutical industry. With a strong emphasis on research and development, the co...

GNG Research Analysis

GNG Research scores Gelteq Limited Ordinary Shares (GELS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for GELS.

Frequently Asked Questions

Does GELS pay dividends?

Gelteq Limited Ordinary Shares (GELS) does not currently pay a regular dividend.

What is GELS's market cap?

Gelteq Limited Ordinary Shares (GELS) has a market capitalization of $5.19M with a current stock price of $0.48.